Genetic susceptibility in pneumoconiosis

Toxicology Letters

Volumn 168, Issue 3, 2007, Pages 249-254

  Yucesoy, Berran ^a   Luster, Michael I ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Genetics; Pneumoconiosis; Susceptibility

Indexed keywords

ANTIOXIDANT; CYTOKINE; GROWTH FACTOR;

ARTICLE; BERYLLIOSIS; CHRONIC INFLAMMATION; DUST; EXPOSURE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; INHALATION; LUNG FIBROSIS; PATHOGENESIS; PNEUMOCONIOSIS; PRIORITY JOURNAL; SILICOSIS;

AIR POLLUTANTS, OCCUPATIONAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PNEUMOCONIOSIS; PULMONARY FIBROSIS;

EID: 33846209241     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.10.021     Document Type: Article

References (58)

1. Atkinson J.J., and Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell. Mol. Biol. 28 1 (2003) 12-24
2. Baecher-Allan C.M., and Barth R.K. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg. Immunol. 5 3-4 (1993) 207-217
3. Borm P.J., and Schins R.P. Genotype and phenotype in susceptibility to coal workers' pneumoconiosis. The use of cytokines in perspective. Eur. Respir. J. Suppl. 32 (2001) 127s-133s
4. Branton M.H., and Kopp J.B. TGF-beta and fibrosis. Microbes Infect. 1 15 (1999) 1349-1365
5. Corbett E.L., Mozzato-Chamay N., Butterworth A.E., De Cock K.M., Williams B.G., Churchyard G.J., and Conway D.J. Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. Am. J. Respir. Crit. Care Med. 165 5 (2002) 690-693
6. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., and O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 5283 (1996) 1856-1862
7. Fukuda Y., Ishizaki M., Kudoh S., Kitaichi M., and Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab. Invest. 78 6 (1998) 687-698
8. Gaede K.I., Amicosante M., Schurmann M., Fireman E., Saltini C., and Muller-Quernheim J. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease. J. Mol. Med. (2005)
9. Henry M.T., McMahon K., Mackarel A.J., Prikk K., Sorsa T., Maisi P., Sepper R., Fitzgerald M.X., and O'Connor C.M. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur. Respir. J. 20 5 (2002) 1220-1227
10. Honda K., Kimura A., Dong R.P., Tamai H., Nagato H., Nishimura Y., and Sasazuki T. Immunogenetic analysis of silicosis in Japan. Am. J. Respir. Cell. Mol. Biol. 8 1 (1993) 106-111
11. Infante P.F., and Newman L.S. Beryllium exposure and chronic beryllium disease. Lancet 363 9407 (2004) 415-416
12. Jagirdar J., Lee T.C., Reibman J., Gold L.I., Aston C., Begin R., and Rom W.N. Immunohistochemical localization of transforming growthfactor beta isoforms in asbestos-related diseases. Environ. Health Perspect. 105S Suppl. 5 (1997) 1197-1203
13. Khalil N., O'Connor R.N., Flanders K.C., and Unruh H. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell. Mol. Biol. 14 2 (1996) 131-138
14. Kim K.A., Cho Y.Y., Cho J.S., Yang K.H., Lee W.K., Lee K.H., Kim Y.S., and Lim Y. Tumor necrosis factor-alpha gene promoter polymorphism in coal workers' pneumoconiosis. Mol. Cell. Biochem. 234-235 1-2 (2002) 205-209
15. Kuwano K., Hagimoto N., and Hara N. Molecular mechanisms of pulmonary fibrosis and current treatment. Curr. Mol. Med. 1 5 (2001) 551-573
16. LeVan T.D., Von Essen S., Romberger D.J., Lambert G.P., Martinez F.D., Vasquez M.M., and Merchant J.A. Polymorphisms in the CD14 gene associated with pulmonary function in farmers. Am. J. Respir. Crit. Care Med. 171 7 (2005) 773-779
17. Liu J.Y., Morris G.F., Lei W.H., Corti M., and Brody A.R. Up-regulated expression of transforming growth factor-alpha in the bronchiolar-alveolar duct regions of asbestos-exposed rats. Am. J. Pathol. 149 1 (1996) 205-217
18. Lombardi G., Germain C., Uren J., Fiorillo M.T., du Bois R.M., Jones-Williams W., Saltini C., Sorrentino R., and Lechler R. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J. Immunol. 166 5 (2001) 3549-3555
19. Maier L.A., McGrath D.S., Sato H., Lympany P., Welsh K., Du Bois R., Silveira L., Fontenot A.P., Sawyer R.T., Wilcox E., and Newman L.S. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J. Immunol. 171 12 (2003) 6910-6918
20. Maier L.A., Raynolds M.V., Young D.A., Barker E.A., and Newman L.S. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 159 4 Pt 1 (1999) 1342-1350
21. Maier L.A., Sawyer R.T., Bauer R.A., Kittle L.A., Lympany P., McGrath D., Dubois R., Daniloff E., Rose C.S., and Newman L.S. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 164 7 (2001) 1192-1199
22. Mastruzzo C., Crimi N., and Vancheri C. Role of oxidative stress in pulmonary fibrosis. Monaldi Arch. Chest. Dis. 57 3-4 (2002) 173-176
23. McCanlies E.C., Ensey J.S., Schuler C.R., Kreiss K., and Weston A. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am. J. Ind. Med. 46 2 (2004) 95-103
24. Nadif R., Jedlicka A., Mintz M., Bertrand J.P., Kleeberger S., and Kauffmann F. Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction Tumour necrosis factor and lymphotoxin alpha. J. Med. Genet. 40 2 (2003) 96-103
25. Nadif R., Mintz M., Rivas-Fuentes S., Jedlicka A., Lavergne E., Rodero M., Kauffmann F., Combadiere C., and Kleeberger S.R. Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis. Cytokine 33 3 (2006) 171-178
26. Pardo A., and Selman M. Molecular mechanisms of pulmonary fibrosis. Front Biosci. 7 (2002) 1743-1761
27. Pardo A., Selman M., Ramirez R., Ramos C., Montano M., Stricklin G., and Raghu G. Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest 102 4 (1992) 1085-1089
28. Phan S.H., and Kunkel S.L. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18 1 (1992) 29-43
29. Piguet P.F., Collart M.A., Grau G.E., Sappino A.P., and Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344 6263 (1990) 245-247
30. Piguet P.F., Vesin C., Grau G.E., and Thompson R.C. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5 1 (1993) 57-61
31. Poller W., Meisen C., and Olek K. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur. J. Clin. Invest. 20 1 (1990) 1-7
32. Raines E.W., Dower S.K., and Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243 4889 (1989) 393-396
33. Ramos C., Montano M., Garcia-Alvarez J., Ruiz V., Uhal B.D., Selman M., and Pardo A. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am. J. Respir. Cell. Mol. Biol. 24 5 (2001) 591-598
34. Richeldi L., Sorrentino R., and Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262 5131 (1993) 242-244
35. Rolfe M.W., Standiford T.J., Kunkel S.L., Burdick M.D., Gilbert A.R., Lynch J.P., and Strieter III R.M. Interleukin-1 receptor antagonist expression in sarcoidosis. Am. Rev. Respir. Dis. 148 5 (1993) 1378-1384
36. Rube C.E., Uthe D., Schmid K.W., Richter K.D., Wessel J., Schuck A., Willich N., and Rube C. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 47 4 (2000) 1033-1042
37. Saltini C., Richeldi L., Losi M., Amicosante M., Voorter C., van den Berg-Loonen E., Dweik R.A., Wiedemann H.P., Deubner D.C., and Tinelli C. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur. Respir. J. 18 4 (2001) 677-684
38. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 8 (1993) 1467-1472
39. Sawyer R.T., Parsons C.E., Fontenot A.P., Maier L.A., Gillespie M.M., Gottschall E.B., Silveira L., and Newman L.S. Beryllium-induced tumor necrosis factor-alpha production by CD4 + T cells is mediated by HLA-DP. Am. J. Respir. Cell. Mol. Biol. 31 1 (2004) 122-130
40. Schaaf B.M., Seitzer U., Pravica V., Aries S.P., and Zabel P. Tumor necrosis factor-alpha-308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. Am. J. Respir. Crit. Care Med. 163 2 (2001) 379-382
41. Schins R.P., and Borm P.J. Mechanisms and mediators in coal dust induced toxicity: a review. Ann. Occup. Hyg. 43 1 (1999) 7-33
42. Selman M., King T.E., and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134 2 (2001) 136-151
43. Selman M., Ruiz V., Cabrera S., Segura L., Ramirez R., Barrios R., and Pardo A. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosisA prevailing nondegradative lung microenvironment?. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 3 (2000) 562-574
44. Shahar I., Fireman E., Topilsky M., Grief J., Kivity S., Spirer Z., and Ben E.S. Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin. Immunol. Immunopathol. 79 3 (1996) 244-251
45. Smith D.R., Kunkel S.L., Standiford T.J., Rolfe M.W., Lynch J.P., 3rd Arenberg D.A., Wilke C.A., Burdick M.D., Martinez F.J., Hampton J.N., et al. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis A compartmental analysis. Am. J. Respir. Crit. Care Med. 151 6 (1995) 1965-1973
46. Takizawa H., Satoh M., Okazaki H., Matsuzaki G., Suzuki N., Ishii A., Suko M., Okudaira H., Morita Y., and Ito K. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters. Clin. Exp. Immunol. 107 1 (1997) 175-181
47. Wahl S.M., McCartney-Francis N., and Mergenhagen S.E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol. Today 10 8 (1989) 258-261
48. Wang X.T., Ohtsuka Y., Kimura K., Muroi M., Ishida T., Saito J., and Munakata M. Antithetical effect of tumor necrosis factor-alphagene polymorphism on coal workers' pneumoconiosis (CWP). Am. J. Ind. Med. 48 1 (2005) 24-29
49. Whyte M., Hubbard R., Meliconi R., Whidborne M., Eaton V., Bingle C., Timms J., Duff G., Facchini A., Pacilli A., Fabbri M., Hall I., Britton J., Johnston I., and Di Giovine F.F. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am. J. Respir. Crit. Care Med. 162 2 Pt 1 (2000) 755-758
50. Williams A.O., Flanders K.C., and Saffiotti U. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. Am. J. Pathol. 142 6 (1993) 1831-1840
51. Yaguchi T., Fukuda Y., Ishizaki M., and Yamanaka N. Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis. Pathol. Int. 48 12 (1998) 954-963
52. Yoshida M., Sakuma J., Hayashi S., Abe K., Saito I., Harada S., Sakatani M., Yamamoto S., Matsumoto N., Kaneda Y., et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc. Natl. Acad. Sci. U.S.A. 92 21 (1995) 9570-9574
53. Yucesoy B., Johnson V.J., Kashon M.L., Fluharty K., Vallyathan V., and Luster M.I. Lack of association between antioxidant gene polymorphisms and progressive massive fibrosis in coal miners. Thorax 60 6 (2005) 492-495
54. Yucesoy B., Vallyathan V., Landsittel D.P., Sharp D.S., Matheson J., Burleson F., and Luster M.I. Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am. J. Ind. Med. 39 3 (2001) 286-291
55. Yucesoy B., Vallyathan V., Landsittel D.P., Sharp D.S., Weston A., Burleson G.R., Simeonova P., McKinstry M., and Luster M.I. Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis. Toxicol. Appl. Pharmacol. 172 1 (2001) 75-82
56. Zhai R., Jetten M., Schins R.P., Franssen H., and Borm P.J. Polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners. Am. J. Ind. Med. 34 4 (1998) 318-324
57. Zhai R., Liu G., Ge X., Yang C., Huang C., Wu C., and Christiani D.C. Genetic polymorphisms of MnSOD, GSTM1, GSTT1, and OGG1 in coal workers' pneumoconiosis. J. Occup. Environ. Med. 44 4 (2002) 372-377
58. Zhang Y., Lee T.C., Guillemin B., Yu M.C., and Rom W.N. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150 9 (1993) 4188-4196